Walden P D, Ruan W, Feldman M, Kleinberg D L
Department of Medicine, Department of Veterans Affairs Medical Center, New York, New York 10010, USA.
Endocrinology. 1998 Feb;139(2):659-62. doi: 10.1210/endo.139.2.5718.
Recent evidence from our laboratory suggests that GH and insulin-like growth factor I (IGF-I) mediate glandular mammary development together with estrogen. It has also been well established that both stromal and epithelial elements must interact for mammary glandular development to occur. To determine whether the effect of GH is mediated by the stromal or epithelial tissue, we set up the following experiment. Bovine GH (bGH; 100 microg) or BSA (as a control), without or with estradiol (E2), was injected i.p. into sexually immature female rats that were hypophysectomized and oophorectomized. Mammary glands and subscapular fat pads were removed from the animals. The mammary glands were divided into two parts: a gland-free fat pad and remaining glandular tissue. The end point of bGH activity was induction of IGF-I messenger RNA (mRNA). This was determined quantitatively by solution hybridization and also by RT-PCR. We found that the effects of GH on stimulation of IGF-I mRNA in the gland-free mammary fat pad and the remainder of the mammary gland were similar (3.6- vs. 3.9-fold, respectively; P < 0.001). In both sorts of mammary tissue, bGH was found to synergize with E2 in the induction of IGF-I mRNA (5.8- vs. 5.3-fold; P < 0.001). There was also an increase in IGF-I mRNA in subscapular fat pads in response to 100 microg bGH (5.3-fold; P < 0.001); however, no synergism between bGH and E2 was found. These data indicate that bGH works as well on mammary stromal tissue as on tissue with glands and suggests that GH acts on the stromal compartment of the mammary gland to induce IGF-I mRNA and possibly IGF-I itself, which, in turn, causes differentiation of epithelial ducts into terminal end buds. These data also might explain why mammary epithelium is also able to differentiate in nonmammary fat pads when transplanted there.
我们实验室最近的证据表明,生长激素(GH)和胰岛素样生长因子I(IGF-I)与雌激素共同介导乳腺的腺性发育。同样已经明确的是,基质和上皮成分必须相互作用才能发生乳腺腺性发育。为了确定GH的作用是由基质组织还是上皮组织介导的,我们进行了以下实验。将牛生长激素(bGH;100微克)或牛血清白蛋白(作为对照),无论有无雌二醇(E2),腹腔注射到已切除垂体和卵巢的性未成熟雌性大鼠体内。从动物身上取出乳腺和肩胛下脂肪垫。将乳腺分为两部分:无腺体的脂肪垫和剩余的腺性组织。bGH活性的终点是诱导IGF-I信使核糖核酸(mRNA)。通过溶液杂交和逆转录聚合酶链反应(RT-PCR)对其进行定量测定。我们发现,GH对无腺体乳腺脂肪垫和乳腺其余部分中IGF-I mRNA的刺激作用相似(分别为3.6倍和3.9倍;P<0.001)。在这两种乳腺组织中,发现bGH与E2协同诱导IGF-I mRNA(5.8倍和5.3倍;P<0.001)。对100微克bGH的反应是肩胛下脂肪垫中IGF-I mRNA也增加(5.3倍;P<0.001);然而,未发现bGH与E2之间有协同作用。这些数据表明,bGH对乳腺基质组织的作用与对有腺体组织的作用相同,提示GH作用于乳腺的基质部分以诱导IGF-I mRNA,可能还有IGF-I本身,进而导致上皮导管分化为终末芽。这些数据也可能解释了为什么乳腺上皮移植到非乳腺脂肪垫中时也能够分化。